Search | ECR Journal

European Cardiology Review

Journal Impact Factor: 3.6

Back to Main Menu

View all platforms

Content for healthcare professionals only

Search results

PROMOTED

HFA 2026: Updates on ATTR-CM

Video Series

Author(s): Marianna Fontana , Added: 3 days ago

How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these… View more

CV Disease in Special Populations

Heart Failure

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Video

Author(s): Christina Magnussen Added: 1 year ago

ACC 2025 - Individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potentially benefit life-years for freedom from CVD and death from any cause.Prof Christina Magnussen (University Heart and Vascular Centre Hamburg, Hamberg, DE) joins us onsite at ACC to discuss modifiable cardiovascular risk factors collected by the Global… View more

Cardiovascular Kidney Metabolic

Symptomology, Outcomes and Risk Factors of Acute Coronary Syndrome Presentations without Cardiac Chest Pain: A Scoping Review

Symptoms, Outcomes, Risk Factors of Atypical ACS: a Scoping Review

Review Article

Author(s): Meriem Perona , Amanda Cooklin , Christopher Thorpe , et al Added: 1 year ago

MI/ACS

Sudden Cardiac Death Risk in Newly Diagnosed Heart Failure: SCD-PROTECT

Video

Author(s): Marat Fudim , David Duncker Added: 3 months ago

In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19… View more

Electrophysiology & Arrhythmia

Heart Failure

SOUL: Oral Semaglutide Improves CV Risk Factors in T2D

News

Added: 3 weeks ago Source: Radcliffe CKM

Mirjam Boros, Radcliffe CardiologyA post hoc secondary analysis of the SOUL trial has found that once-daily oral semaglutide is associated with early and sustained improvements in multiple cardiovascular (CV) risk factors in high-risk patients with type 2 diabetes (T2D).¹ These findings help to explain the mechanisms behind the primary trial results, which showed a 14% reduction in major adverse… View more

Cardiovascular Kidney Metabolic

Heart Failure